ArticleJournal of breast cancer2017

Cardioprotective Effect of Dexrazoxane in Patients with HER2-Positive Breast Cancer Who Receive Anthracycline Based Adjuvant Chemotherapy Followed by Trastuzumab.

In-Ho Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.